Top Companies in the Computer Vision in Healthcare Market
◉International Business Machines (IBM) Corporation
a. Overview: IBM is an American multinational technology corporation, well known for its expertise in cloud computing, artificial intelligence, and enterprise solutions.
b. Product/Role in Healthcare: IBM integrates computer vision into its Watson Health solutions, leveraging AI to support imaging analysis and diagnostic accuracy.
c. Strength: IBM’s financial stability underpins its technological advancements. In Q4 2024, revenue reached USD 14.541 billion, a 0.55% increase from Q4 2023. For the full year 2024, IBM’s revenue was USD 62.832 billion, marking a 1.23% year-on-year rise. Its global presence and enterprise AI expertise strengthen its role in healthcare innovation.
◉SenseTime
a. Overview: SenseTime is a Hong Kong-based AI company, recognized for its advanced computer vision platforms.
b. Product/Role in Healthcare: The company’s SenseCare platform applies AI algorithms and image processing to healthcare, enabling diagnostic imaging and clinical decision support.
c. Strength: In 2024, SenseTime’s revenue was RMB 3,772.1 million, growing 10.8% year-on-year. Its specialization in scalable AI platforms makes it a leader in applying CV to healthcare imaging and diagnosis.
◉Artisight
a. Overview: Artisight develops AI-based smart hospital platforms, combining computer vision, IoT, and machine learning to optimize hospital operations.
b. Product/Role in Healthcare: It supports workflow automation, real-time patient monitoring, and surgical coordination through AI-powered CV platforms.
c. Strength: The company’s strong collaborations, including its partnership with KARL STORZ to launch the Pathway.AI platform in 2024, enhance its presence in surgical efficiency solutions.
◉Caregility Corporation
a. Overview: Caregility is a U.S.-based telehealth company that integrates computer vision into virtual care and patient monitoring solutions.
b. Product/Role in Healthcare: Its iObserver platform uses CV to detect fall risks and analyze patient behavior in real-time, running AI entirely on telehealth edge devices in patient rooms.
c. Strength: Caregility’s strength lies in merging telehealth infrastructure with CV, enabling continuous patient observation without overburdening healthcare staff.
◉Google, LLC
a. Overview: Google is a global technology leader with expertise in cloud computing, deep learning, and AI-based healthcare research.
b. Product/Role in Healthcare: Through Google Cloud and AI research, the company applies CV in medical imaging analysis, early detection of diseases, and healthcare predictive analytics.
c. Strength: Its vast cloud ecosystem and AI leadership provide scalability and speed for healthcare providers adopting CV solutions.
◉Microsoft Corporation
a. Overview: Microsoft is a leading global technology provider with strong healthcare AI initiatives.
b. Product/Role in Healthcare: Microsoft Azure Cognitive Services for Computer Vision powers healthcare AI models such as the Florence model, improving diagnostic imaging and clinical validation.
c. Strength: With deep enterprise reach and cloud infrastructure, Microsoft drives global adoption of CV solutions through scalable, secure platforms.
◉NVIDIA Corporation
a. Overview: NVIDIA is the global leader in GPU and AI hardware acceleration.
b. Product/Role in Healthcare: Its GPUs power advanced imaging systems, deep learning models, and real-time CV processing in healthcare.
c. Strength: NVIDIA’s hardware and CUDA software ecosystem form the backbone of AI-driven healthcare applications, offering unmatched speed and accuracy for CV tasks.
◉KARL STORZ
a. Overview: KARL STORZ is a German medical device company specializing in surgical instruments and endoscopy solutions.
b. Product/Role in Healthcare: It integrates CV into surgical visualization and workflow optimization platforms. Its Pathway.AI collaboration with Artisight exemplifies this.
c. Strength: The company’s reputation in surgical technologies gives it a competitive edge in integrating CV into operating rooms.
◉Iterative Health
a. Overview: Iterative Health is a U.S.-based healthcare AI company focused on gastroenterology.
b. Product/Role in Healthcare: It develops CV-powered solutions for endoscopic imaging, improving detection of gastrointestinal diseases such as colorectal cancer.
c. Strength: Its niche focus on gastroenterology provides depth in a critical healthcare specialty, driving adoption of CV for precision diagnostics.
◉Viso.AI
a. Overview: Viso.AI offers computer vision infrastructure platforms for building and deploying AI vision applications.
b. Product/Role in Healthcare: It supports hospitals and diagnostic centers in developing custom CV tools for imaging, monitoring, and research.
c. Strength: The company’s flexible platform approach allows healthcare organizations to adopt and scale AI-based CV without deep technical expertise.
Latest Announcement by Industry Leaders
◉ Roberta Schwartz, Chief Innovation Officer at Houston Methodist Hospital, emphasized the practical benefits of AI-driven computer vision in surgical environments:
a. She explained that real-time insights powered by AI and visuals from ceiling-mounted cameras enable surgeons to prepare better and manage caseloads efficiently.
b. AI was noted to forecast scheduling changes throughout the day, optimizing operating room workflows.
c. These insights improve team coordination and resource productivity, allowing hospitals to increase surgical case volumes without compromising quality of care.
d. Importantly, such systems reduce the burden on perioperative staff, who are often overstressed by manual coordination and unexpected scheduling disruptions.
Recent Developments in the Computer Vision in Healthcare Market
◉University of Auckland Research – May 2024
a. Researchers demonstrated the role of computer vision in identifying abnormalities during surgical procedures.
b. The study showed that CV not only improves intraoperative detection but also supports hospitals burdened by high patient volumes.
c. By enhancing monitoring systems, CV enables remote patient tracking, helping individuals recover safely at home and easing the load on hospital infrastructure.
◉Caregility Corporation – April 2024
a. Caregility launched its iObserver platform, designed to continuously monitor patients at risk of self-harm or falls.
b. The system uses computer vision to analyze visual cues in patient rooms, identifying fall risks and alerting caregivers in real time.
c. iObserver’s unique feature is that AI runs entirely on telehealth edge devices within the patient room, ensuring quick response times without relying on external servers.
d. This innovation aligns with the broader push to integrate AI into telehealth, reducing staffing pressures and ensuring safer patient care.
Segments Covered in the Computer Vision in Healthcare Market
1. By Component
◉Hardware Segment – Dominant in 2024
a. The hardware segment held the leading share of the market in 2024 due to strong healthcare infrastructure and growing investment in advanced diagnostic equipment.
b. Key devices such as X-ray machines, CT scanners, MRI systems, and endoscopy tools are increasingly integrated with computer vision technologies to improve diagnostic accuracy.
c. Researchers are constantly upgrading imaging hardware with CV algorithms to improve visualization, reduce diagnostic errors, and enhance real-time functionality.
d. The rise of wearable medical devices with embedded sensors has also boosted hardware demand, as CV enables remote monitoring of vital signs and patient health.
◉Software Segment – Fastest Growing
a. The software segment is projected to witness significant growth over the forecast period, driven by demand from healthcare professionals working in facilities with limited infrastructure.
b. CV-based software algorithms are cost-effective, user-friendly, and do not require heavy capital investments, making them accessible across hospitals and diagnostic centers.
c. Software plays a critical role in disease detection, surgical guidance, and managing large volumes of clinical trial and imaging data.
d. CV-enabled mobile apps enhance patient adherence by verifying medication intake and treatment compliance, expanding the scope of software solutions.
◉Services Segment – Supportive Growth
a. Services include training, maintenance, and technical support for deploying CV technologies in hospitals and diagnostic centers.
b. Growing outsourcing of AI and computer vision integration to specialized vendors supports this segment.
c. Services also include customization of CV tools to match the needs of healthcare providers, enabling smoother adoption.
2 By Product Type
◉PC-Based Computer Vision Systems – Market Leader in 2024
a. PC-based CV systems dominated the market in 2024 as most healthcare organizations globally are equipped with computer infrastructure.
b. These systems are capable of handling multiple camera inputs and processing complex datasets, making them versatile for diverse clinical applications.
c. PC-based systems also provide higher computational power and flexibility compared to smart cameras, supporting both entry-level and advanced healthcare uses.
◉Smart Camera-Based Computer Vision Systems – Rapid Growth
a. Smart camera-based systems are gaining popularity due to their affordability, simplicity, and independence from specialized installation infrastructure.
b. They are integrated with microprocessors and programmed to handle imaging algorithms directly, reducing reliance on external computing devices.
c. Growing demand is driven by their reliability and ability to streamline imaging tasks in smaller healthcare facilities.
d. Advancements in smart camera technology make them suitable for patient monitoring, fall detection, and bedside diagnostics.
3. By Application
◉Medical Imaging & Diagnostics – Dominant Application in 2024
a. This segment held the largest share of the market in 2024 due to CV’s critical role in automating and improving diagnostic imaging.
b. CV technologies enhance accuracy by detecting minor abnormalities in imaging data that may be overlooked by human eyes.
c. They are widely applied in radiology, oncology, cardiology, and neurology for early disease detection and treatment monitoring.
d. Studies indicate CV can achieve up to 90% accuracy in differentiating medical images, significantly improving clinical decision-making.
◉Surgeries – Fastest Growing Application
a. The surgeries segment is projected to expand rapidly due to the increasing number of global surgeries, estimated at more than 313 million annually.
b. CV assists surgeons in identifying bleeding, blocked arteries, and hidden abnormalities during procedures, reducing error risks.
c. It enables recognition of surgical phases, tools, and anomalies in real time, improving precision and safety.
d. With WHO reporting that unsafe care harms 1 in 10 patients, CV technologies have a strong role in minimizing surgical errors and preventing avoidable fatalities.
◉Patient Management & Research
a. CV aids in monitoring patients post-surgery and during recovery, ensuring safety and faster intervention when complications arise.
b. It is also used in clinical research for analyzing trial data, monitoring medication adherence, and tracking disease progression.
c. In long-term care, CV solutions help in continuous monitoring, reducing the burden on healthcare staff while improving patient outcomes.
◉Others
a. This includes applications in drug discovery, pathology, and epidemic prediction, where CV analyzes vast datasets to assist in preventive measures.
b. It also supports medical training, creating real-time simulations to train healthcare professionals.
4. By End-User
◉Healthcare Providers – Largest Share in 2024
a. Healthcare providers such as hospitals and clinics dominated the market in 2024, adopting CV technologies for early diagnosis, treatment planning, and recovery monitoring.
b. Providers use CV to predict illness risks, improve preventive care, and enhance treatment outcomes.
c. CV also supports training of medical staff, reducing errors and ensuring high-quality care delivery.
◉Diagnostic Centers – Rapid Expansion
a. Diagnostic centers are expected to grow significantly due to their infrastructure and capital capacity to invest in advanced CV-enabled imaging tools.
b. CV assists in quick segmentation and categorization of medical images, increasing diagnostic accuracy in diseases like orthopedic and cardiovascular disorders.
c. Its ability to speed up and automate workflows saves physicians’ time, enabling higher throughput in diagnostic services.
◉Academic Research Institutes
a. Universities and research organizations use CV for developing and validating new imaging models and disease detection algorithms.
b. They also apply CV in experimental studies, drug research, and advanced AI-based healthcare innovations.
◉Others
a. Includes home healthcare services and telehealth platforms using CV-enabled tools for patient monitoring, fall detection, and treatment adherence tracking.
5. By Region
◉North America – Dominant in 2024
a. Strong healthcare infrastructure, presence of major AI companies, and favorable funding policies supported regional dominance.
b. U.S. initiatives like the “Precision Medicine Initiative” drive CV integration for personalized treatments.
c. Canada’s “AI4H Guiding Principles” encourage ethical adoption of CV in healthcare systems.
◉Asia-Pacific – Fastest Growing
a. High population base, rising chronic disease prevalence, and growing awareness of CV technologies drive adoption.
b. China launched Robodoc Hospital in 2024, run entirely by robots using CV and AI, setting a benchmark in healthcare innovation.
c. Japan’s “Society 5.0” initiative promotes AI-based hospitals, boosting CV demand.
◉Europe – Steady Growth
a. The EU4Health program supports digital adoption, resilience, and innovation in healthcare systems.
b. Germany’s “Digital Act” fosters healthcare digitization, while the UK’s high expenditure and hospital admissions push adoption.
◉Latin America – Emerging Market
a. Governments in Argentina and Brazil are advancing digitization and AI adoption in healthcare.
b. Brazil’s Secretariat of Information and Digital Health focuses on digital transformation within public health systems.
◉Middle East and Africa (MEA)
a. Growing investments in digital health infrastructure in countries like UAE, Saudi Arabia, and South Africa are boosting CV adoption.
b. Favorable government strategies aim to modernize healthcare systems with AI-driven technologies.
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5585
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest